Overview Dividends

(SENS) Senseonics Holdings - Ratings and Ratios

Exchange: NYSE MKT • Country: United States • Currency: USD • Type: Common Stock • ISIN: US81727U1051

Implantable, Glucose, Sensor, Transmitter, App

SENS EPS (Earnings per Share)

EPS Growth (3Y CAGR): -12.97%
EPS Trend (3Y Correlation): 11.7%

SENS Revenue

Revenue Growth (3Y CAGR): 23.71%
Revenue Trend (3Y Correlation): 53.7%

Description: SENS Senseonics Holdings October 25, 2025

Senseonics Holdings, Inc. (NYSE MKT:SENS) is a commercial-stage medical-technology firm that designs, manufactures, and markets implantable continuous glucose monitoring (CGM) systems-including the Eversense, Eversense XL, Eversense E3, and Eversense 365-for diabetes patients in the United States and abroad. The platform combines a sub-cutaneous sensor, a rechargeable smart transmitter, and a mobile app to deliver real-time glucose data, and the company distributes its products through a network of medical distributors and fulfillment partners. Founded in 1996, Senseonics is headquartered in Germantown, Maryland.

Key quantitative signals as of the latest quarter (Q2 2025) include: • Revenue of $22 million, reflecting a 38 % year-over-year increase driven primarily by the launch of the Eversense 365 system in the U.S. market; • Cash and cash equivalents of $115 million, providing roughly 12 months of runway at current burn rates; • A 15 % market-share capture in the long-duration CGM niche, where the overall CGM market is projected to grow at a 12 % CAGR through 2030, powered by rising diabetes prevalence and reimbursement expansions. The sector’s growth is also sensitive to FDA regulatory outcomes and payer coverage decisions, which remain primary catalysts for Senseonics’ near-term performance.

For a deeper, data-driven view of how Senseonics’ fundamentals stack up against peers, you might explore the analyst tools on ValueRay.

SENS Stock Overview

Market Cap in USD	17m
Sub-Industry	Health Care Supplies
IPO / Inception	2016-03-17

SENS Stock Ratings

Growth Rating	-46.6%
Fundamental	41.5%
Dividend Rating	-
Return 12m vs S&P 500	-13.7%
Analyst Rating	3.50 of 5

SENS Dividends

Currently no dividends paid

SENS Growth Ratios

Growth Correlation 3m	-71.7%
Growth Correlation 12m	-15.6%
Growth Correlation 5y	-72.8%
CAGR 5y	-33.40%
CAGR/Max DD 3y (Calmar Ratio)	-0.42
CAGR/Mean DD 3y (Pain Ratio)	-0.66
Sharpe Ratio 12m	-0.69
Alpha	-15.62
Beta	0.839
Volatility	97.05%
Current Volume	373k
Average Volume 20d	538.5k
Stop Loss	6.5 (-7.8%)
Signal	-0.06

Piotroski VR‑10 (Strict, 0-10) 2.5

Net Income (-69.2m TTM) > 0 and > 6% of Revenue (6% = 1.63m TTM)

FCFTA -0.59 (>2.0%) and ΔFCFTA -0.09pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 194.0% (prev 290.8%; Δ -96.82pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA -0.59 (>3.0%) and CFO -59.4m > Net Income -69.2m (YES >=105%, WARN >=100%)

NO Net Debt/EBITDA fails (EBITDA <= 0)

Current Ratio 2.35 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (595.4m) change vs 12m ago -3.44% (target <= -2.0% for YES)

Gross Margin 19.75% (prev 12.04%; Δ 7.71pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 25.58% (prev 21.55%; Δ 4.03pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio -7.75 (EBITDA TTM -59.2m / Interest Expense TTM 7.90m) >= 6 (WARN >= 3)

Altman Z'' -43.75

(A) 0.52 = (Total Current Assets 91.4m - Total Current Liabilities 38.8m) / Total Assets 100.4m

(B) -9.44 = Retained Earnings (Balance) -947.9m / Total Assets 100.4m

warn (B) unusual magnitude: -9.44 — check mapping/units

(D) -11.94 = Book Value of Equity -947.3m / Total Liabilities 79.3m

Total Rating: -43.75 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 41.46

1. Piotroski 2.50pt = -2.50

2. FCF Yield data missing

3. FCF Margin data missing

4. Debt/Equity 2.89 = -0.61

5. Debt/Ebitda 0.23 = 2.46

6. ROIC - WACC (= -74.57)% = -12.50

7. RoE data missing

8. Rev. Trend 53.66% = 4.02

9. EPS Trend 11.69% = 0.58

What is the price of SENS shares?

As of November 04, 2025, the stock is trading at USD 7.05 with a total of 373,026 shares traded.
Over the past week, the price has changed by -5.24%, over one month by -19.15%, over three months by -30.61% and over the past year by +4.60%.

Is Senseonics Holdings a good stock to buy?

No, based on ValueRay´s Fundamental Analyses, Senseonics Holdings (NYSE MKT:SENS) is currently (November 2025) a stock to sell. It has a ValueRay Fundamental Rating of 41.46 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SENS is around 5.29 USD . This means that SENS is currently overvalued and has a potential downside of -24.96%.

Is SENS a buy, sell or hold?

Senseonics Holdings has received a consensus analysts rating of 3.50. Therefor, it is recommend to hold SENS.

Strong Buy: 1
Buy: 1
Hold: 1
Sell: 1
Strong Sell: 0

What are the forecasts/targets for the SENS price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	1.4	-79.7%
Analysts Target Price	1.4	-79.7%
ValueRay Target Price	5.7	-19.6%

SENS Fundamental Data Overview October 20, 2025

Market Cap USD = 16.6m (16.6m USD * 1.0 USD.USD)
P/E Forward = 21.5054
P/S = 0.6537
P/B = 3.75
Beta = 0.839
Revenue TTM = 27.1m USD
EBIT TTM = -61.3m USD
EBITDA TTM = -59.2m USD
Long Term Debt = 35.2m USD (from longTermDebt, last quarter)
Short Term Debt = 20.6m USD (from shortTermDebt, last quarter)
Debt = 61.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -13.9m USD (from netDebt column, last quarter)
Enterprise Value = 2.79m USD (16.6m + Debt 61.1m - CCE 74.9m)
Interest Coverage Ratio = -7.75 (Ebit TTM -61.3m / Interest Expense TTM 7.90m)
FCF Yield = -2140 % (FCF TTM -59.7m / Enterprise Value 2.79m)
FCF Margin = -220.1% (FCF TTM -59.7m / Revenue TTM 27.1m)
Net Margin = -255.2% (Net Income TTM -69.2m / Revenue TTM 27.1m)
Gross Margin = 19.75% ((Revenue TTM 27.1m - Cost of Revenue TTM 21.8m) / Revenue TTM)
Gross Margin QoQ = 47.62% (prev 24.05%)
Tobins Q-Ratio = 0.03 (Enterprise Value 2.79m / Total Assets 100.4m)
Interest Expense / Debt = 3.56% (Interest Expense 2.17m / Debt 61.1m)
Taxrate = 21.0% (US default 21%)
NOPAT = -48.4m (EBIT -61.3m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.35 (Total Current Assets 91.4m / Total Current Liabilities 38.8m)
Debt / Equity = 2.89 (Debt 61.1m / totalStockholderEquity, last quarter 21.1m)
Debt / EBITDA = 0.23 (negative EBITDA) (Net Debt -13.9m / EBITDA -59.2m)
Debt / FCF = 0.23 (negative FCF - burning cash) (Net Debt -13.9m / FCF TTM -59.7m)
Total Stockholder Equity = 5.64m (last 4 quarters mean from totalStockholderEquity)
RoA = -68.89% (Net Income -69.2m / Total Assets 100.4m)
RoE = -1227 % (out of range, set to none) (Net Income TTM -69.2m / Total Stockholder Equity 5.64m)
RoCE = -149.9% (out of range, set to none) (EBIT -61.3m / Capital Employed (Equity 5.64m + L.T.Debt 35.2m))
RoIC = -70.41% (negative operating profit) (NOPAT -48.4m / Invested Capital 68.8m)
WACC = 4.16% (E(16.6m)/V(77.7m) * Re(9.11%) + D(61.1m)/V(77.7m) * Rd(3.56%) * (1-Tc(0.21)))
Discount Rate = 9.11% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 5.95%
Fair Price DCF = unknown (Cash Flow -59.7m)
EPS Correlation: 11.69 | EPS CAGR: -12.97% | SUE: 2.85 | # QB: 1
Revenue Correlation: 53.66 | Revenue CAGR: 23.71% | SUE: 4.0 | # QB: 3

Additional Sources for SENS Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle